These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9203188)

  • 1. Low peripheral plasma renin activity as a critical marker in pediatric hypertension.
    Yiu VW; Dluhy RP; Lifton RP; Guay-Woodford LM
    Pediatr Nephrol; 1997 Jun; 11(3):343-6. PubMed ID: 9203188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.
    Fardella CE; Mosso L; Gómez-Sánchez C; Cortés P; Soto J; Gómez L; Pinto M; Huete A; Oestreicher E; Foradori A; Montero J
    J Clin Endocrinol Metab; 2000 May; 85(5):1863-7. PubMed ID: 10843166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic analyses of the chimeric CYP11B1/CYP11B2 gene in a Korean family with glucocorticoid-remediable aldosteronism.
    Lee IS; Kim SY; Jang HW; Kim MK; Lee JH; Lee YH; Jo YS
    J Korean Med Sci; 2010 Sep; 25(9):1379-83. PubMed ID: 20808686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of glucocorticoid-remediable aldosteronism in hypertensive children.
    Kamrath C; Maser-Gluth C; Haag C; Schulze E
    Horm Res Paediatr; 2011; 76(2):93-8. PubMed ID: 21625068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid-remediable aldosteronism in a large kindred: clinical spectrum and diagnosis using a characteristic biochemical phenotype.
    Rich GM; Ulick S; Cook S; Wang JZ; Lifton RP; Dluhy RG
    Ann Intern Med; 1992 May; 116(10):813-20. PubMed ID: 1567095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Chinese pedigree with glucocorticoid remediable aldosteronism.
    Liu X; Jin L; Zhang H; Ma W; Song L; Zhou X; Cai J
    Hypertens Res; 2021 Nov; 44(11):1428-1433. PubMed ID: 34462604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Contribution of CYP11B2, REN and AGT genes in genetic predisposition to arterial hypertension associated with hyperaldosteronism].
    Chikhladze NM; Samedova KhF; Sudomoina MA; Thant M; Htut ZM; Litonova GN; Favorov AV; Chazova IE; Favorova OO
    Kardiologiia; 2008; 48(1):37-42. PubMed ID: 18260994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Low-renin hypertension and inherited mineralocorticoid diseases].
    Kastelan D; Giljević Z; Perković Z; Plavsić V; Breskovac L; Aganović I; Korsić M
    Lijec Vjesn; 1999; 121(7-8):245-9. PubMed ID: 10573960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Japanese family with glucocorticoid-remediable aldosteronism diagnosed by long-polymerase chain reaction.
    Yokota K; Ogura T; Kishida M; Suzuki J; Otsuka F; Mimura Y; Oishi T; Hirata M; Tobe K; Makino H
    Hypertens Res; 2001 Sep; 24(5):589-94. PubMed ID: 11675955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Remediable glucocorticoid hyperaldosteronism: molecular diagnosis].
    Lurbe E; Chaves FJ; Torró I; Armengod ME; Alvarez V; Redon J
    Med Clin (Barc); 1999 Nov; 113(15):579-82. PubMed ID: 10605685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of familial hyperaldosteronism type 1 in a hypertensive pediatric population: clinical and biochemical presentation.
    Aglony M; Martínez-Aguayo A; Carvajal CA; Campino C; García H; Bancalari R; Bolte L; Avalos C; Loureiro C; Trejo P; Brinkmann K; Giadrosich V; Mericq V; Rocha A; Avila A; Perez V; Inostroza A; Fardella CE
    Hypertension; 2011 Jun; 57(6):1117-21. PubMed ID: 21502562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the dexamethasone suppression test for the diagnosis of glucocorticoid-remediable aldosteronism.
    Litchfield WR; New MI; Coolidge C; Lifton RP; Dluhy RG
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3570-3. PubMed ID: 9360508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid-remediable aldosteronism.
    Williams GH; Dluhy RG
    J Endocrinol Invest; 1995; 18(7):512-7. PubMed ID: 9221269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New genetic insights in familial hyperaldosteronism.
    Jackson RV; Lafferty A; Torpy DJ; Stratakis C
    Ann N Y Acad Sci; 2002 Sep; 970():77-88. PubMed ID: 12381543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new presentation of the chimeric CYP11B1/CYP11B2 gene with low prevalence of primary aldosteronism and atypical gene segregation pattern.
    Carvajal CA; Campino C; Martinez-Aguayo A; Tichauer JE; Bancalari R; Valdivia C; Trejo P; Aglony M; Baudrand R; Lagos CF; Mellado C; Garcia H; Fardella CE
    Hypertension; 2012 Jan; 59(1):85-91. PubMed ID: 22083159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldosterone-producing adenomas do not contain glucocorticoid-remediable aldosteronism chimeric gene duplications.
    Carroll J; Dluhy R; Fallo F; Pistorello M; Bradwin G; Gomez-Sanchez CE; Mortensen R
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4310-2. PubMed ID: 8954032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism.
    Fallo F; Pilon C; Williams TA; Sonino N; Morra Di Cella S; Veglio F; De Iasio R; Montanari P; Mulatero P
    J Hum Hypertens; 2004 Jan; 18(1):47-51. PubMed ID: 14688810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and pathological diversity of primary aldosteronism, including a new familial variety.
    Gordon RD; Stowasser M; Tunny TJ; Klemm SA; Finn WL; Krek AL
    Clin Exp Pharmacol Physiol; 1991 May; 18(5):283-6. PubMed ID: 2065471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoid remediable aldosteronism: low morbidity and mortality in a four-generation italian pedigree.
    Mulatero P; di Cella SM; Williams TA; Milan A; Mengozzi G; Chiandussi L; Gomez-Sanchez CE; Veglio F
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3187-91. PubMed ID: 12107222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.